TRISHA BUSH: Open Payments
NPI 1518537133 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 61 payments from 13 companies in 2025. Trend: 2023 $1,910 · 2024 $2,069 · 2025 $1,911
Food & beverage: $1,783Education: $128
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $338 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $333 |
| Janssen Biotech, Inc. | 9 | $266 |
| Lilly USA, LLC | 4 | $258 |
| Novartis Pharmaceuticals Corporation | 8 | $188 |
| ABBVIE INC. | 10 | $180 |
| GENZYME CORPORATION | 4 | $109 |
| UCB, Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 1 | $43 |
Products named: NEMLUVIO, TREMFYA, EBGLYSS, ILUMYA, DUPIXENT, SKYRIZI, COSENTYX, Bimzelx.
Industry payments across TN — which companies pay providers there.
